Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1206 (31 May), doi:10.1136/bmj.a162
| The first 150 words of the full text of this article appear below. |
Finally, our attention is brought to the mythology of AIDS in our community.1 In November 2007 UNAIDS reported that the AIDS pandemic was not increasing, global HIV prevalence being 33.2 million in 2007 and 39.5 million in 2006 and global HIV incidence 2.5 million in 2007 and 4.3 million in 2006.2
The original proposition that HIV was exceptional led to such public health diversions as the use of option C by the Global Fund to Fight HIV/AIDS: procurement of products not reviewed by a regulatory authority. In 2007, of 2254 single or limited source products procured, a fifth was purchased using option C.3
The exceptionality of AIDS posited that price was the barrier on access to medicines for the poor. This ignored the incipient causes of HIV and AIDS: "The prime mover of the epidemic is not inadequate antiretroviral medications, poverty, or bad luck but our inability to accept the
Jeremiah Norris, director
1 Center for Science in Public Policy, Hudson Institute, 15th Street, NW, Washington, DC, 20005, USA
jeannie@hudson.org